You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
13. De Laurentiis M, Arpino G, Massarelli E, Ruggiero A, Carlomagno C,<br />
Ciardiello F, Tortora G, D'Agostino D, Caputo F, Cancello G, Montagna E,<br />
Malorni L, Zinno L, Lauria R, Bianco AR, De Placido S 2005 A meta-analysis<br />
on the interaction between H<strong>ER</strong>-2 expression and response to endocrine treatment<br />
in advanced breast cancer. Clin Cancer Res 11:4741-8<br />
14. Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, Schiff R<br />
2004 Mechanisms of tamoxifen resistance: increased estrogen receptor-H<strong>ER</strong>2/neu<br />
cross-talk in <strong>ER</strong>/H<strong>ER</strong>2-positive breast cancer. J Natl Cancer Inst 96:926-35<br />
15. Chung YL, Sheu ML, Yang SC, Lin CH, Yen SH 2002 Resistance to<br />
tamoxifen-induced apoptosis is associated with direct interaction between<br />
Her2/neu and cell membrane estrogen receptor in breast cancer. Int J Cancer<br />
97:306-12<br />
16. Stoica GE, Franke TF, Wellstein A, Czubayko F, List HJ, Reiter R, Morgan<br />
E, Martin MB, Stoica A 2003 Estradiol rapidly activates Akt via the ErbB2<br />
signaling pathway. Mol Endocrinol 17:818-30<br />
17. Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang Z,<br />
Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ,<br />
Vadlamudi RK 2002 A naturally occurring MTA1 variant sequesters oestrogen<br />
receptor-alpha in the cytoplasm. Nature 418:654-7<br />
18. Nicholson RI, McClelland RA, Finlay P, Eaton CL, Gullick WJ, Dixon AR,<br />
Robertson JF, Ellis IO, Blamey RW 1993 Relationship between EGF-R, c-<br />
erbB-2 protein expression and Ki67 immunostaining in breast cancer and<br />
hormone sensitivity. Eur J Cancer 7:1018-23<br />
43
Change language